tiprankstipranks
Trending News
More News >
Tempest Therapeutics (TPST)
NASDAQ:TPST
US Market

Tempest Therapeutics (TPST) Stock Forecast & Price Target

Compare
1,260 Followers
See the Price Targets and Ratings of:

TPST Analyst Ratings

Currently, no data available
Based on NaN analysts giving stock ratings to
Tempest
Therapeutics
in the past 3 months
TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers​ in the past 3 months

TPST Stock 12 Month Forecast

There Are No Analyst Ratings for TPST In The Last 3 Months.
Highest Price TargetAverage Price TargetLowest Price Target
The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.

TPST Financial Forecast

TPST Earnings Forecast

The previous quarter’s earnings for TPST were -$0.79.
The previous quarter’s earnings for TPST were -$0.79.
No data currently available

TPST Sales Forecast

The previous quarter’s earnings for TPST were $0.00.
The previous quarter’s earnings for TPST were $0.00.

Detailed List of Analyst Forecasts​

Detailed List of Analyst Forecasts​
Analyst Profile
Expert Firm
Price Target
Position
Upside / Downside
Action
Date
Follow
Article
H.C. Wainwright Analyst forecast on TPST
H.C. Wainwright
H.C. Wainwright
Hold
Reiterated
05/15/25
Tempest Therapeutics: Navigating Financial Challenges with Promising Clinical Data and Strategic Partnerships
Scotiabank Analyst forecast on TPST
Scotiabank
Scotiabank
$9
Hold
252.94%
Upside
Reiterated
05/14/25
Analysts' Opinions Are Mixed on These Healthcare Stocks: Tempest Therapeutics (NASDAQ: TPST) and Astria Therapeutics (NASDAQ: ATXS)
Piper Sandler Analyst forecast on TPST
Piper Sandler
Piper Sandler
$65
Buy
2449.02%
Upside
Reiterated
03/28/25
Piper Sandler Reaffirms Their Buy Rating on Tempest Therapeutics (TPST)
Analyst Type
Any
Any
Human Analysts
Ranks
Any
Any
Analyst Rating
Any
Any
Upside/ Downside
Any
Any
Action
Any
Any
Analyst Profile
Expert Firm
Price Target
Position
Upside / Downside
Action
Date
Follow
Article
H.C. Wainwright Analyst forecast on TPST
H.C. Wainwright
H.C. Wainwright
Hold
Reiterated
05/15/25
Tempest Therapeutics: Navigating Financial Challenges with Promising Clinical Data and Strategic Partnerships
Scotiabank Analyst forecast on TPST
Scotiabank
Scotiabank
$9
Hold
252.94%
Upside
Reiterated
05/14/25
Analysts' Opinions Are Mixed on These Healthcare Stocks: Tempest Therapeutics (NASDAQ: TPST) and Astria Therapeutics (NASDAQ: ATXS)
Piper Sandler Analyst forecast on TPST
Piper Sandler
Piper Sandler
$65
Buy
2449.02%
Upside
Reiterated
03/28/25
Piper Sandler Reaffirms Their Buy Rating on Tempest Therapeutics (TPST)
Stocks with the Highest Top Analyst Consensus in the Healthcare Sector
Find stocks in the Healthcare sector that are highly recommended by Top Performing Analysts.

Best Analysts Covering Tempest Therapeutics

3 Months
xxx
Success Rate
1/9 ratings generated profit
11%
Average Return
-24.16%
reiterated a xxx
rating 10 months ago
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 3 Months would result in 11.11% of your transactions generating a profit, with an average return of -24.16% per trade.
1 Year
Edward TenthoffPiper Sandler
Success Rate
2/9 ratings generated profit
22%
Average Return
-10.82%
reiterated a buy rating 10 months ago
Copying Edward Tenthoff's trades and holding each position for 1 Year would result in 22.22% of your transactions generating a profit, with an average return of -10.82% per trade.
2 Years
xxx
Success Rate
2/9 ratings generated profit
22%
Average Return
-53.29%
reiterated a xxx
rating 10 months ago
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 2 Years would result in 22.22% of your transactions generating a profit, with an average return of -53.29% per trade.
The Best Analyst Covering tool allows you to follow the analysts who have the best success rates and average returns on a specific stock. Only analysts that gave a Buy or Sell rating on the stock in the past 12 months are eligible for inclusion in this tool. Follow the analysts of your choice to receive real-time updates when they publish a new rating.

TPST Analyst Recommendation Trends

Rating
Sep 25
Oct 25
Nov 25
Dec 25
Jan 26
Strong Buy
0
0
0
0
0
Buy
0
0
0
0
0
Hold
0
0
0
0
0
Sell
0
0
0
0
0
Strong Sell
0
0
0
0
0
total
0
0
0
0
0
In the current month, TPST has received 0 Buy Ratings, 0 Hold Ratings, and 0 Sell Ratings. TPST average Analyst price target in the past 3 months is .
Each month's total comprises the sum of three months' worth of ratings.

TPST Stock Forecast FAQ

What is TPST’s average 12-month price target, according to analysts?
Currently, no data Available
What is TPST’s upside potential, based on the analysts’ average price target?
Currently there's no upside potential for TPST, based on the analysts’ average price target.
Can I see which stocks the top-ranking analysts are rating?
Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
    How can I follow the stock ratings of top Wall Street analysts?
    Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
      Is TPST a Buy, Sell or Hold?
      Currently, no data Available
      What is Tempest Therapeutics’s price target?
      Currently, no data Available
      What do analysts say about Tempest Therapeutics?
      Not enough analysts have published a price target to provide an average price target.
      How can I buy shares of TPST?
      Open a brokerage account, see exclusive account opening deals on our Best Online Brokers page.